Search by Drug Name or NDC
NDC 00378-8136-01 EXTINA 20 mg/g Details
EXTINA 20 mg/g
EXTINA is a TOPICAL AEROSOL, FOAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is KETOCONAZOLE.
MedlinePlus Drug Summary
Ketoconazole cream is used to treat tinea corporis (ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes), tinea versicolor (fungal infection of the skin that causes brown or light colored spots on the chest, back, arms, legs, or neck), and yeast infections of the skin. Prescription ketoconazole shampoo is used to treat tinea versicolor. Over-the-counter ketoconazole shampoo is used to control flaking, scaling, and itching of the scalp caused by dandruff. Ketoconazole is in a class of antifungal medications called imidazoles. It works by slowing the growth of fungi that cause infection.
Related Packages: 00378-8136-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ketoconazole Topical
Product Information
| NDC | 00378-8136 |
|---|---|
| Product ID | 0378-8136_6082e3cc-c1da-4df0-9937-e9fe551ecc5d |
| Associated GPIs | 90154045003920 |
| GCN Sequence Number | 063088 |
| GCN Sequence Number Description | ketoconazole FOAM 2 % TOPICAL |
| HIC3 | Q5F |
| HIC3 Description | TOPICAL ANTIFUNGALS |
| GCN | 98848 |
| HICL Sequence Number | 004132 |
| HICL Sequence Number Description | KETOCONAZOLE |
| Brand/Generic | Brand |
| Proprietary Name | EXTINA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ketoconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | AEROSOL, FOAM |
| Route | TOPICAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/g |
| Substance Name | KETOCONAZOLE |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021738 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 00378-8136-01 (00378813601)
| NDC Package Code | 0378-8136-01 |
|---|---|
| Billing NDC | 00378813601 |
| Package | 100 g in 1 CAN (0378-8136-01) |
| Marketing Start Date | 2019-01-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |